MARKET

FBIO

FBIO

Fortress Biotech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.580
-0.230
-8.19%
After Hours: 2.580 0 0.00% 18:55 01/17 EST
OPEN
2.790
PREV CLOSE
2.810
HIGH
2.800
LOW
2.560
VOLUME
841.36K
TURNOVER
--
52 WEEK HIGH
2.840
52 WEEK LOW
1.000
MARKET CAP
181.47M
P/E (TTM)
-2.8289
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of FBIO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

FBIO News

  • The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom Disappointment Inflicts Pain On Durect Shares
  • Benzinga.12h ago
  • The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom Disappointment Inflicts Pain On Durect Shares
  • Benzinga.12h ago
  • Loss-Making Fortress Biotech, Inc. (NASDAQ:FBIO) Expected To Breakeven
  • Simply Wall St..13h ago
  • Fortress Biotech Granted FDA Rare Pediatric Disease Designation For CUTX-101 For The Treatment Of Menkes Disease
  • Benzinga.1d ago

More

Industry

Pharmaceuticals
+0.13%
Pharmaceuticals & Medical Research
+0.07%

Hot Stocks

Name
Price
%Change

About FBIO

Fortress Biotech, Inc.(Fortress) is a biopharmaceutical company that acquires, develops and commercializes novel pharmaceutical and biotechnology products. Fortress develops and commercializes products both within Fortress and through certain of its subsidiary companies. Fortress has 11 operating subsidiaries that include: 4 commercial stage programs, 25 development stage programs, targeting 6 therapeutic areas: Immuno-oncology, Hematology, Gene Therapy, Pain Management, Rare Diseases and Dermatology. In addition to its internal development programs, Fortress leverages its biopharmaceutical business expertise and drug development capabilities and provides funding and management services to help the Fortress Companies. Fortress subsidiaries include Aevitas Therapeutics, Avenue Therapeutics, Caelum Biosciences, Cellvation, Inc., Checkpoint Therapeutics, Cyprium Therapeutics, Helocyte, Inc., Journey Medical Corporation, Mustang Bio and Tamid Bio, Inc.
More

Webull offers Fortress Biotech Inc (FBIO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.